Equine Platelet Enhancement Therapy


  • Complete disposable system for production of PRP designed for patient-side administration.
  • No capital equipment required
  • Average 7.2 fold increase in platelet concentration
  • Processing takes on average 10 minutes
  • Closed system to avoid contamination
  • Average 8ml final solution which can be used in whole or frozen in part for later use
  • Ideal for soft tissue injury or activated for wound regeneration
  • Platelets remain inactivated until point of treatment
  • Price and quality guarantee
  • Trusted and used by veterinarians around the world

Ideal for the use in treatment of:

Pall Corporation
E-Pet is a brand name of PALL

Tendon and Ligament Injury

Using enriched autologous platelets causes an increase in essential growth factors (including IFG-1, PDGF, VEGF, TGF-beta, bFGF, IGF-1 and PF4,5) which accelerate tissue repair and regeneration at the site of injury.

Use in Osteoarthritis

Studies have shown that platelet-released growth factors enhance the secretion of hyaluronic acid and induce hepatocyte growth factor production by synovial fibroblasts and readily bind to the tyrosine kinase receptors on the surface of stem cells. Once the receptors have been stimulated, a signal is sent to the nucleus of the stem cells leading to cell growth and proliferation.

Use in Wound Care

The release of platelet derived growth factors cause a chemotactic response which initiates the process of migration between the endothelial cells. As more growth factors continue to be released, angiogenesis and the formation of interlocking collagen bundles as organised tissue occur. This helps speed the wound healing process.
V-Care Biomedical offers a service based on the most up to date research and development derived from the work of leading academics around the world.